Cargando…
Off‐target effects of bacillus Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2: implications for protection against severe COVID‐19
BACKGROUND AND OBJECTIVES: Because of its beneficial off‐target effects against non‐mycobacterial infectious diseases, bacillus Calmette–Guérin (BCG) vaccination might be an accessible early intervention to boost protection against novel pathogens. Multiple epidemiological studies and randomised con...
Autores principales: | Messina, Nicole L, Germano, Susie, McElroy, Rebecca, Rudraraju, Rajeev, Bonnici, Rhian, Pittet, Laure F, Neeland, Melanie R, Nicholson, Suellen, Subbarao, Kanta, Curtis, Nigel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028103/ https://www.ncbi.nlm.nih.gov/pubmed/35573165 http://dx.doi.org/10.1002/cti2.1387 |
Ejemplares similares
-
Neonatal Bacillus Calmette-Guérin Vaccination to Prevent Early-Life Eczema: A Systematic Review and Meta-analysis
por: Pittet, Laure F., et al.
Publicado: (2022) -
The safety of co-administration of Bacille Calmette-Guérin (BCG) and influenza vaccines
por: Villanueva, Paola, et al.
Publicado: (2022) -
Revaccination with Bacille Calmette-Guérin (BCG) is associated with an increased risk of abscess and lymphadenopathy
por: Villanueva, Paola, et al.
Publicado: (2022) -
Bacillus Calmette–Guérin Immunotherapy for Cancer
por: Cardillo, Fabíola, et al.
Publicado: (2021) -
The Contribution of Non-Conventional T Cells and NK Cells in the Mycobacterial-Specific IFNγ Response in Bacille Calmette-Guérin (BCG)-Immunized Infants
por: Zufferey, Christel, et al.
Publicado: (2013)